MetaCap

Relmada Therapeutics Insider Trades

NASDAQ: RLMDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.62-0.49 (-15.76%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
6 · $1.83M
Sales
0 · $0
Shares bought / sold
439.17K / 0
Net activity
Net buying $1.8 million

Relmada Therapeutics insider activity

Over the last 12 months, Relmada Therapeutics insiders reported 6 transactions on SEC Form 4: 6 open-market purchases and 0 sales. Insiders bought $1.8 million and sold $0 worth of stock, for net insider buying of $1.8 million. The most recent filing shows Shenouda Maged (Chief Financial Officer) buying 79,800 shares at $4.25 on Sep 10, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RLMD's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

RLMD insider transactions

Relmada Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 10, 2026TRAVERSA SERGIOChief Executive OfficerBuy100,000$410.00KForm 4
Sep 10, 2026Shenouda MagedChief Financial OfficerBuy79,800$339.15KForm 4
Sep 9, 2026TRAVERSA SERGIOChief Executive OfficerBuy100,000$418.00KForm 4
Sep 9, 2026Shenouda MagedChief Financial OfficerBuy120,200$504.84KForm 4
Dec 15, 2025Shenouda MagedChief Financial OfficerBuy11,665$48.06KForm 4
Dec 15, 2025TRAVERSA SERGIOChief Executive OfficerBuy27,500$113.30KForm 4
Nov 5, 2025Kelly Paul EdwardChief Operating OfficerBuy90,000$198.00KForm 4
Nov 5, 2025TRAVERSA SERGIOChief Executive OfficerBuy272,500$599.50KForm 4
Nov 5, 2025Shenouda MagedChief Financial OfficerBuy500,000$1.10MForm 4
Nov 5, 2025Ence ChuckCAO and COOBuy136,000$299.20KForm 4
Aug 28, 2025TRAVERSA SERGIOChief Executive OfficerBuy55,976$41.42KForm 4
Aug 27, 2025TRAVERSA SERGIOChief Executive OfficerBuy129,455$86.73KForm 4
Aug 26, 2025TRAVERSA SERGIOChief Executive OfficerBuy80,545$49.94KForm 4
May 20, 2025TRAVERSA SERGIOChief Executive OfficerBuy147,686$82.25KForm 4
May 20, 2025Shenouda MagedChief Financial OfficerBuy60,000$31.42KForm 4
May 19, 2025TRAVERSA SERGIOChief Executive OfficerBuy30,000$14.99KForm 4
May 19, 2025Shenouda MagedChief Financial OfficerBuy90,000$43.69KForm 4
May 16, 2025TRAVERSA SERGIOChief Executive OfficerBuy172,314$77.47KForm 4
May 16, 2025Ence ChuckCA and COBuy228,961$103.33KForm 4
May 16, 2025Shenouda MagedChief Financial OfficerBuy50,000$22.10KForm 4
May 16, 2025Kelly Paul EdwardChief Operating OfficerBuy200,000$86.06KForm 4
Oct 22, 2024CASAMENTO CHARLES JDirectorGift13,000—Form 4
Sep 11, 2024Shenouda MagedChief Financial OfficerBuy24,120$71.15KForm 4
Sep 11, 2024TRAVERSA SERGIOChief Executive OfficerBuy51,407$153.71KForm 4
Sep 10, 2024Shenouda MagedChief Financial OfficerBuy21,118$57.65KForm 4
Sep 10, 2024TRAVERSA SERGIOChief Executive OfficerBuy33,014$90.79KForm 4
Sep 9, 2024Kelly Paul EdwardDirectorBuy25,000$64.75KForm 4
Sep 9, 2024Shenouda MagedChief Financial OfficerBuy8,194$20.89KForm 4
Sep 9, 2024CASAMENTO CHARLES JDirectorBuy13,000$33.28KForm 4
Sep 9, 2024TRAVERSA SERGIOChief Executive OfficerBuy55,579$150.62KForm 4
Jan 31, 2024Ence ChuckCA and COBuy13,670$55.43KForm 4
Jan 31, 2024Shenouda MagedChief Financial OfficerBuy6,875$27.94KForm 4
Jan 31, 2024TRAVERSA SERGIOChief Executive OfficerBuy27,460$109.75KForm 4
Jan 30, 2024Ence ChuckCA and COBuy14,500$56.05KForm 4
Jan 30, 2024Shenouda MagedChief Financial OfficerBuy15,000$58.32KForm 4
Jan 30, 2024TRAVERSA SERGIOChief Executive OfficerBuy40,999$159.95KForm 4
Jan 29, 2024Ence ChuckCA and COBuy10,800$39.44KForm 4
Jan 29, 2024Shenouda MagedChief Financial OfficerBuy10,800$39.45KForm 4
Jan 29, 2024TRAVERSA SERGIOChief Executive OfficerBuy31,541$117.04KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related